Sienna Biopharmaceuticals, Inc. (SNNAQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 26, 2025, 8:00 PM EDT
Sienna Biopharmaceuticals Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SNNAQ has 22.78 million shares outstanding.
| Current Share Class | 22.78M |
| Shares Outstanding | 22.78M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.00% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.44.
| Current Ratio | 4.00 |
| Quick Ratio | 2.30 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.19 |
| Interest Coverage | -23.99 |
Financial Efficiency
Return on equity (ROE) is -140.97% and return on invested capital (ROIC) is -49.84%.
| Return on Equity (ROE) | -140.97% |
| Return on Assets (ROA) | -32.10% |
| Return on Invested Capital (ROIC) | -49.84% |
| Return on Capital Employed (ROCE) | -111.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -3.69M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 118.01 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 98.56 |
| Average Volume (20 Days) | 7 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -43.18M |
| Pretax Income | -52.57M |
| Net Income | -47.95M |
| EBITDA | -43.02M |
| EBIT | -43.18M |
| Earnings Per Share (EPS) | -1.80 |
Balance Sheet
The company has 11.33 million in cash and 10.28 million in debt, giving a net cash position of 1.05 million or 0.05 per share.
| Cash & Cash Equivalents | 11.33M |
| Total Debt | 10.28M |
| Net Cash | 1.05M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 23.10M |
| Book Value Per Share | 0.75 |
| Working Capital | 14.80M |
Cash Flow
In the last 12 months, operating cash flow was -54.63 million and capital expenditures -10,000, giving a free cash flow of -54.64 million.
| Operating Cash Flow | -54.63M |
| Capital Expenditures | -10,000 |
| Free Cash Flow | -54.64M |
| FCF Per Share | -2.40 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SNNAQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.18% |
| Shareholder Yield | -31.18% |
| Earnings Yield | -2,104,960.49% |
| FCF Yield | -2,398,551.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |